These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32073874)

  • 1. Effects of
    Shayesteh M; Vaez-Mahdavi MR; Shams J; Kamalinejad M; Faghihzadeh S; Gholami-Fesharaki M; Gharebaghi R; Heidary F
    J Altern Complement Med; 2020 May; 26(5):398-408. PubMed ID: 32073874
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Violet oil, a traditional Iranian formula, in patients with chronic insomnia: A randomized, double-blind, placebo-controlled study.
    Feyzabadi Z; Rezaeitalab F; Badiee S; Taghipour A; Moharari F; Soltanifar A; Ahmadpour MR
    J Ethnopharmacol; 2018 Mar; 214():22-28. PubMed ID: 29217495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sedative effects of an intranasal dosage form containing saffron, lettuce seeds and sweet violet in primary chronic insomnia: A randomized, double-dummy, double-blind placebo controlled clinical trial.
    Taherzadeh Z; Khaluyan H; Iranshahy M; Rezaeitalab F; Eshaghi Ghalibaf MH; Javadi B
    J Ethnopharmacol; 2020 Nov; 262():113116. PubMed ID: 32736046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Viola odorata syrup on sleep quality in menopausal women: a randomized, triple-blind, controlled trial.
    Karimi FZ; Nazari N; Lotfi F; Mazloom SR; Yousefi M; Rakhshandeh H
    Sleep Breath; 2024 Jun; 28(3):1137-1144. PubMed ID: 38177831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-blind controlled trial.
    Adel Mehraban MS; Shirzad M; Mohammad Taghizadeh Kashani L; Ahmadian-Attari MM; Safari AA; Ansari N; Hatami H; Kamalinejad M
    J Ethnopharmacol; 2023 Mar; 304():116058. PubMed ID: 36535329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
    Sarris J; Oliver G; Camfield DA; Dean OM; Dowling N; Smith DJ; Murphy J; Menon R; Berk M; Blair-West S; Ng CH
    CNS Drugs; 2015 Sep; 29(9):801-9. PubMed ID: 26374743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.
    Ghaleiha A; Entezari N; Modabbernia A; Najand B; Askari N; Tabrizi M; Ashrafi M; Hajiaghaee R; Akhondzadeh S
    J Psychiatr Res; 2013 Feb; 47(2):175-80. PubMed ID: 23063327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial.
    Farnia V; Gharehbaghi H; Alikhani M; Almasi A; Golshani S; Tatari F; Davarinejad O; Salemi S; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2018 Sep; 104():137-143. PubMed ID: 30044966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of fluvoxamine combined with extended-release methylphenidate on treatment-refractory obsessive-compulsive disorder].
    Zheng H; Jia F; Guo G; Quan D; Li G; Huang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1230-1235. PubMed ID: 30643068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of
    Ho YT; Tsai YC; Kuo TBJ; Yang CCH
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Double-Blind Randomized Placebo-Controlled Pilot Study of Azithromycin in Youth with Acute-Onset Obsessive-Compulsive Disorder.
    Murphy TK; Brennan EM; Johnco C; Parker-Athill EC; Miladinovic B; Storch EA; Lewin AB
    J Child Adolesc Psychopharmacol; 2017 Sep; 27(7):640-651. PubMed ID: 28358599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder.
    Sayyah M; Boostani H; Pakseresht S; Malayeri A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):362-5. PubMed ID: 20035818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control.
    Yousefzadeh F; Sahebolzamani E; Sadri A; Mortezaei A; Aqamolaei A; Mortazavi SH; Shalbafan MR; Ghaffari S; Alikhani R; Mousavi SB; Naderi S; Shamabadi A; Jalilevand S; Akhondzadeh S
    Int Clin Psychopharmacol; 2020 Sep; 35(5):254-262. PubMed ID: 32541380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aloysia citriodora Palau (lemon verbena) for insomnia patients: A randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
    Afrasiabian F; Mirabzadeh Ardakani M; Rahmani K; Azadi NA; Alemohammad ZB; Bidaki R; Karimi M; Emtiazy M; Hashempur MH
    Phytother Res; 2019 Feb; 33(2):350-359. PubMed ID: 30450627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial.
    Grant JE; Hook R; Valle S; Chesivoir E; Chamberlain SR
    Int Clin Psychopharmacol; 2021 Sep; 36(5):225-229. PubMed ID: 34310432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lettuce seed syrup on insomnia in patients with breast cancer: a pilot double blind randomized placebo controlled clinical trial.
    Mosavat SH; Mirzaei HR; Mofid B; Gharehgozlou R; Parvizi MM; Bradley R; Pasalar M; Heydarirad G
    J Complement Integr Med; 2022 Dec; 19(4):999-1005. PubMed ID: 34455726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial.
    Gowda SM; Narayanaswamy JC; Hazari N; Bose A; Chhabra H; Balachander S; Bhaskarapillai B; Shivakumar V; Venkatasubramanian G; Reddy YCJ
    Brain Stimul; 2019; 12(4):922-929. PubMed ID: 30808612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial.
    Carmi L; Tendler A; Bystritsky A; Hollander E; Blumberger DM; Daskalakis J; Ward H; Lapidus K; Goodman W; Casuto L; Feifel D; Barnea-Ygael N; Roth Y; Zangen A; Zohar J
    Am J Psychiatry; 2019 Nov; 176(11):931-938. PubMed ID: 31109199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.